Literature DB >> 6266206

Free light chains of immunoglobulins in serum from patients with rheumatoid arthritis, sarcoidosis, chronic infections and pulmonary cancer.

K Sølling, J Sølling, F K Rømer.   

Abstract

Free light chains of immunoglobulins were measured in serum from 181 patients with rheumatoid arthritis (RA), sarcoidosis, pulmonary tuberculosis, pulmonary cancer and chronic bronchitis, i.e. patients with long-term stimulation of the immune system. Increased concentrations of light chains were found in patients with active sarcoidosis, and the light chain level appeared to be a marker of disease activity in sarcoidosis. The mean (+/- S.D.) concentration of kappa plus lambda chains in active sarcoidosis of more than two years' duration was 38.3 +/- 13.7 mg/l, that is twice the concentration of 19.4 +/- 5.5 mg/l found in normals. Some patients with seropositive RA also had increased serum values. The light chain concentrations in seropositive RA were correlated to the severity of the disease measured by clinical staging and laboratory tests. A modest increase in light chains was observed in one patient with tuberculosis, and in two patients each with chronic bronchitis and pulmonary cancer.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6266206     DOI: 10.1111/j.0954-6820.1981.tb11632.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  11 in total

1.  Circulating antibody free light chains and risk of posttransplant lymphoproliferative disorder.

Authors:  E A Engels; J Preiksaitis; A Zingone; O Landgren
Journal:  Am J Transplant       Date:  2012-02-02       Impact factor: 8.086

2.  Urine free light chains in SLE: clonal markers of B-cell activity and potential link to in vivo secreted Ig.

Authors:  J E Hopper; J Golbus; C Meyer; G A Ferrer
Journal:  J Clin Immunol       Date:  2000-03       Impact factor: 8.317

3.  Differences in kappa to lambda (kappa:lambda) ratios of serum and urinary free light chains.

Authors:  M Abe; T Goto; M Kosaka; D Wolfenbarger; D T Weiss; A Solomon
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

4.  Elicitation of allergic asthma by immunoglobulin free light chains.

Authors:  Aletta D Kraneveld; Mirjam Kool; Anneke H van Houwelingen; Paul Roholl; Alan Solomon; Dirkje S Postma; Frans P Nijkamp; Frank A Redegeld
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-14       Impact factor: 11.205

5.  Serum free light chains and the risk of ESRD and death in CKD.

Authors:  Richard Haynes; Colin A Hutchison; Jonathan Emberson; Tanaji Dasgupta; David C Wheeler; John N Townend; Martin J Landray; Paul Cockwell
Journal:  Clin J Am Soc Nephrol       Date:  2011-10-27       Impact factor: 8.237

6.  Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome.

Authors:  J-E Gottenberg; F Aucouturier; J Goetz; C Sordet; I Jahn; M Busson; J-M Cayuela; J Sibilia; X Mariette
Journal:  Ann Rheum Dis       Date:  2006-03-28       Impact factor: 19.103

7.  Elevation of serum immunoglobulin free light chains during the preclinical period of rheumatoid arthritis.

Authors:  Xiaoli Deng; Cynthia S Crowson; S Vincent Rajkumar; Angela Dispenzieri; Dirk R Larson; Terry M Therneau; Eric L Matteson; Robert A Kyle; Jerry A Katzmann; Sherine E Gabriel; John M Davis
Journal:  J Rheumatol       Date:  2015-01-15       Impact factor: 4.666

8.  Consequences of receptor editing at the lambda locus: multireactivity and light chain secretion.

Authors:  Colleen M Doyle; Jiong Han; Martin G Weigert; Eline T Luning Prak
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-17       Impact factor: 11.205

9.  Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease.

Authors:  Colin A Hutchison; Stephen Harding; Pete Hewins; Graham P Mead; John Townsend; Arthur R Bradwell; Paul Cockwell
Journal:  Clin J Am Soc Nephrol       Date:  2008-11       Impact factor: 8.237

10.  Association of serum TNF-α, IL-8 and free light chain with HLA-DR B alleles expression in pulmonary and extra-pulmonary sarcoidosis.

Authors:  Esmaeil Mortaz; Hale Abdoli Sereshki; Atefeh Abedini; Arda Kiani; Mehdi Mirsaeidi; Dina Soroush; Johan Garssen; Aliakbar Velayati; Frank A Redegeld; Ian M Adcock
Journal:  J Inflamm (Lond)       Date:  2015-03-19       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.